Literature DB >> 9552377

Chemical inhibitors of cyclin-dependent kinases.

L Meijer1.   

Abstract

The eukaryotic cell division cycle is regulated by a family of protein kinases, the cyclin-dependent kinases (cdk's), constituted of at least two subunits, a catalytic subunit (cdk1-7) associated with a regulatory subunit (cyclin A-H). Transient activation of cdk's is responsible for transition through the different phases of the cell cycle. Major abnormalities of cdk's expression and regulation have been described in human tumours. Enzymatic screening is starting to uncover chemical inhibitors of cdk's with anti-mitotic activities. This review summarizes our knowledge of these first inhibitors, their mechanism of action, their effects on the cell cycle, and discusses the potential of such type of inhibitors as anti-tumour agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9552377     DOI: 10.1007/978-1-4615-1809-9_29

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  14 in total

1.  Regulation of the 26S proteasome by adenovirus E1A.

Authors:  A S Turnell; R J Grand; C Gorbea; X Zhang; W Wang; J S Mymryk; P H Gallimore
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.

Authors:  A Montagnoli; F Fiore; E Eytan; A C Carrano; G F Draetta; A Hershko; M Pagano
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

3.  Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.

Authors:  H Nguyen; D M Gitig; A Koff
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells.

Authors:  K Fukuoka; J Usuda; Y Iwamoto; H Fukumoto; T Nakamura; T Yoneda; N Narita; N Saijo; K Nishio
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

6.  Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues.

Authors:  A Kálnay; I Pályi; B Vincze; R Mihalik; I Mezõ; J Pató; J Seprõdi; S Lovas; R F Murphy
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

7.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.

Authors:  J W Pippin; Q Qu; L Meijer; S J Shankland
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.

Authors:  Mohamed Salah I Abaza; Abdul-Majeed A Bahman; Rajaa J Al-Attiyah
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

10.  Etomidate reduces glutamate uptake in rat cultured glial cells: involvement of PKA.

Authors:  M Räth; K J Föhr; H U Weigt; A Gauss; J Engele; M Georgieff; S Köster; O Adolph
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.